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second one at the 18 months. From the control Group 6 patients died in the ﬁrst year,
in the next six months 3 more patients died and all 6 patients stayed in III and the rest
in IV functional class. The left fraction ejection improve in a average 5%, but in all the
patients the therapeutic medication were reduced. From the control group we found
that 80% of the patients were hospitalized around 3 or 4 times per year and in the
experimental group only 10%.
Conclusion: This technique is effective for treat patients with refractory heart
failure, besides being easy to apply, during the procedure there were no deaths, and
functional class improved signiﬁcantly for patients in a period of 6 months until
these period. The containment of the discinetique zone with a mechanical barrier
effect, promoted the consequent increase in the contractility of the rest of the walls.
This clinical trial is innovative for the treatment of refractory heart failure using a
percutaneous technique.
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Multi-Center Prospective Study to Evaluate Outcomes of Moderate to Severely
Calcified Coronary Lesions (MACE): Study Design and Acute Outcomes
Samin Sharma
Mount Sinai Medical Center, NY, NY
Background: Recently presented retrospective analysis comparing none, moderate,
and severely calciﬁed coronary lesions showed that percutaneous coronary intervention
(PCI) patients that have moderate/severely calciﬁed coronary lesions have poorer
outcomes than patients with none/mild calciﬁed coronary lesions.
Methods: MACE study conducted by Cardiovascular Systems Inc. (CSI) is the ﬁrst
study that will prospectively monitor PCI outcomes in patients with varied degrees of
calciﬁcation in coronary lesions. This study will enroll up to 500 subjects in up to 50
U.S. study sites. The objectives of the MACE study are to: 1) assess current standard
of care treatment outcomes in none/mild (n¼100), moderate (n¼200), and severe
(n¼200) calciﬁed coronary lesions. 2) Obtain ﬁnancial data and procedure data to
support reimbursement initiatives and health care economics analysis. Subjects
scheduled for endovascular treatment involving stent deployment in de novo coronary
lesions are qualiﬁed to be included in the study. Endovascular treatment is deﬁned as
treatment with commercially available devices that may include but is not limited to
balloon, cutting balloon, Rotablator, etc. followed by the stent placement. The subjects
will not be included in the study if 1) diagnosed with chronic renal failure unless under
hemodialysis or has a serum creatinine level >2.5 mg/dl; 2) have evidence of current
LVEF 25%; 3) have history of major cardiac intervention within 30 days, not
including a PCI procedure for a staging purpose; 4) have uncontrolled insulin
dependent diabetes.
Results: The primary endpoint is to assess the current standard of care treatment
when used to facilitate stent deployment in de novo, coronary lesions. This will be
measured by a composite of major adverse cardiac events (MACE) at 30 days and
1-year post procedure. MACE is composed of cardiac death; myocardial infarction
(MI) – deﬁned as a CK-MB level > 3 times the upper limit of lab normal (ULN) value
with or without new pathologic Q wave; and target vessel revascularization (TVR) –
deﬁned as revascularization at the target vessel (inclusive of the target lesion) after the
completion of the index procedure. Secondary endpoints include procedural success
and health economics.
Conclusion: An interim analysis of acute outcomes will be presented on up to 50
subjects that have completed the discharge visit.CRT-160
Same Day Discharge After Elective Percutaneous Coronary Interventions: A Single
Center Experience in Contrast to the National Average
Pradeep K. Yadav, Giselle A. Baquero, Ronald Maag, Ian C. Gilchrist
Pennsylvania State University, Hershey, PA
Background: Patients undergoing elective Percutaneous Coronary Interventions
(PCI) are generally observed overnight in the hospitals, mainly because of the fear of
the PCI related complications. Prevalence of same day discharge after elective PCI is
still very low in the United States (1.5% as quoted in recent studies), with variation
across the facilities and the operators.
Methods: Information from a pre-existing quality assurance database was dei-
dentiﬁed and used in this retrospective review. All patients undergoing elective
PCI between a 2 year period at a single center with ﬁve different operators were
selected. Information regarding clinical characteristics, co-morbidities, anatomic
& procedural details, immediate complications, re-hospitalization and mortality
within 30 days was collected.
Results: 372 patients had elective PCI, 95 (25.5%) were discharged the same day.
Among the radial group, 78 (36.6%) out of 213 patients and femoral 17(10.8%) of the
157 patients were discharged the same day. One of the operators discharged 82% (37/
45) of his elective patients the same day. 30% of the patients had age >70 years, 15%
had GFR <60 and 2% had GFR <30, 24% had LVEF <60 and 2.1% had LVEF
<30. None of them had immediate procedural complications. Overall, there were no
deaths at 30 days and four patients were hospitalized. Post procedure day 3 sub acute
stent thrombosis due to clopidogrel non compliance, day 9 with radial artery
pseudoaneurysm, and day 28 with chest pains, none of which could have been
prevented by overnight hospital stay.
Conclusions: Same day discharge after elective PCI at our institution was
signiﬁcantly higher than the national average and had operator variability. There
was no mortality, post procedural complications or repeat hospitalizations within
30 days that could have been prevented with overnight observation. Simple suc-
cess or failure of the procedure without intraprocedural complications seems to be
the important distinguishing feature of a PCI that can deﬁne who can safely be
discharged.
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Utility of Clinical Risk Scoring Systems in Predicting Long Term Outcome After
Percutaneous Coronary Intervention in a Veterans Affairs Medical Center
Aravind Sekhar, Prafull Raheja, Lakshmana Pendyala, Ali Usmani, Shoaib Akbar,
Deepali Tukaye, Ibrahim Abu Romeh, Ram C. Sharma, Melissa Lester, Sohail Ikram
Veterans Affairs Medical Center, Louisville, KY
Background: Veterans Affairs Medical Center (VAMC) patients undergoing after
Percutaneous Coronary Intervention (PCI) have multiple co-morbidities and cardio-
vascular risk factors. The NCDR Risk score is a clinical risk score to predict the risk of
in-patient mortality after PCI. The ACEF is a simpler clinical risk scoring system that
incorporates 3 variables- Age, Creatinine and Ejection Fraction to predict outcomes
after PCI and is a predictor of death 1 year post procedure.
Objective: We wanted to evaluate if these clinical scores are applicable to a VAMC
population and assess its utility in predicting long term survival outcomes and compare
the scoring systems.
Methods: NCDR risk scores and ACEF scores were calculated for 361 consecutive
patients undergoing PCI and were correlated with their 3 year mortality. Kaplan-
Meier (KM) Survival Analyses of low (10), intermediate (11 to 30) and high (>30)
NCDR score were performed with 3 year mortality data. ACEF and NCDR scores
were co-related with their 3 year outcomes.
Results: Average ACEF score of patients who died during the 3 year follow up were
signiﬁcantly lower than those who survived. None of the 65 patients with NCDR score
10 died while 22 of the 52 (42%) with a score >30 died within 3 years. KM survival
analyses of patients stratiﬁed by NCDR score conﬁrmed signiﬁcant increase in the 3
year mortality of the patients with higher scores. This is the ﬁrst report comparing
NCDR and ACEF scores in a VA population with long term survival outcomes.
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follow up are higher than those who survive. NCDR score appears to correlate better
with 3 year mortality and predicts long term survival outcomes after PCI in the VA
population better than ACEF and can assist improved resource utilization within the
VA for PCI.C
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Long-Term Clinical Outcome in Patients with Peripheral Arterial Disease Underwent
Percutaneous Coronary Intervention with Drug-Eluting Stent
Woong Gil Choi,1 Seung-Woon Rha,2 Byoung Geol Choi,2 Se Yeon Choi,2 Sang-Ho Park,3
Ji Young Park,4 Yun-Hyeong Cho,5 Won-Yu Kang,6 Dong Joo Oh2
1Cardiology, Chungju Kunkuk University, Chungju, Korea, Republic of; 2Cardiovascular
Center, Korea University Guro Hospital, Seoul, Korea, Republic of; 3Cardiology
Department, Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of;
4Cardiovascular Center, Eulji University, Eulji General Hospital, Seoul, Korea, Republic
of; 5Cardiovascular Center, Myongji Hospital, Goyang, Korea, Republic of;
6Cardiovascular Center, Kwanju Bohoon General Hospital, Kwangju, Korea,
Republic of
Background: Peripheral arterial disease (PAD) is an important predictor of adverse
clinical outcomes following coronary revascularization. Patients with PAD have been
found to have higher rates of adverse outcomes and poorer survival compared with
patients without PAD. However, there have been limited data for long term clinical
outcomes in patients with PAD undergoing percutaneous coronary intervention (PCI)
in drug eluting stent (DES) era.
Method: The study population consisted of 2903 consecutive patients underwent
PCI from April 2007 to November 2010. Two-year cumulative major clinical
outcomes of patients with PAD (n¼101) were compared with patients without
PAD (n¼2802).
Result: Baseline characteristics were balanced except patients with PAD were older
(66.76  10.1 vs. 62.90  11.3 years, p ¼ 0.020), had more diabetes (61.8 vs. 27.6 %,
p ¼ 0.002) and had longer total lesion length (50.38  47.14 mm vs. 41.24  39.93
mm, p ¼ 0.005). Patients with PAD showed a strong trend toward higher rate of total
mortality (13.6 vs. 6.3%, p ¼ 0.051) despite of successful PCI results, but there was no
signiﬁcant difference in the incidence of cardiac death, target lesion revascularization(TLR), target vessel revascularization (TVR) and major adverse cardiac events
(MACE, Table).
Conclusion: In our study, patients with PAD were associated with higher trend of
increased total mortality up to 2 years as compared with those without PAD group
following successful PCI, suggesting more special care should be exercised for this
particular subset of patients.
Table. Two-year cumulative major clinical outcomesVariable, n (%)
Patient with PAD
(n¼101 pts)
Patients without PAD
(n¼2802pts) P value
Total mortality 6 (13.6) 122 (6.3) 0.051Cardiac death 3 (6.8) 78 (4.0) 0.356Myocardial infarction 0 (0) 31 (1.6) 0.398TLR 5 (11.4) 156 (8.1) 0.428TVR 10 (22.7) 310 (16) 0.232Total MACE 10 (22.7) 376 (19.4) 0.585TLR, TVR; target lesion and vessel revascularization
MACE; major adverse cardiac events
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Increasing Trends of Obese Patients Undergoing Percutaneous Coronary Intervention
From 1988 to 2006
Mohammad Reza Movahed,1 Mehrtash Hashemzadeh,2 Mehnoosh Hashemzadeh3
1CareMore HeathCare and University of Arizona, Tucson, AZ; 2Long Beach VA
Healthcare System, Tucson, AZ; 3PIMA College, Tucson, AZ
Background: We recently published increasing trend in the rate of percutaneous
coronary intervention (PCI) In the United States. The goal of this study was to
evaluate this trend in obese patient undergoing PCI in the United States.
Method: The Nationwide Inpatient Sample (NIS) database was utilized to calculate
the age-adjusted incident rate of PCI performed in obese patient from 1988 to 2006 in
the United States using ICD-9 coding.
Results: A total population of 122,023 obese patients underwent PCI between 1988-
2006 were available for our study. We found that age adjusted rate of PCI performed
in obese patient gradually increased with highest rate in 2006. Age adjusted rate for
Obese patients undergoing PCI was PCI per 100,000 in 1988 was 2.7 vs. 24.1 per
100.000 in 2006 (p<0.01). Non-obese patient had similar increase in PCI over the
years studied.
Conclusion: PCI performed in obese patient had increased steadily in last few de-
cades. The cause of this trend is not known but could be related to increasing in obesity
incidence or PCI is performed more frequently in high risk patients.
